Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Start 7-day free trial → Log in

DITEST

Small molecule · Agonist of androgen receptor (AR) · developed by Neurocrine UK

Phase 1 Most advanced trial (none active)

NBIX Developer

1 Registered trials

What is DITEST?

DITEST is a lipid formulation of native oral testosterone for treatment of male hypogonadism. It acts as an agonist of the androgen receptor to restore testosterone levels in hypogonadal men.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type: Small molecule
Targets: androgen receptor (AR)
Mechanism: Agonist of androgen receptor (AR)
Therapy area: Endocrine
Developer: Neurocrine UK Limited (NBIX)
FDA status: Investigational, not approved in the US. Most advanced trial: Phase 1

🧪 Clinical trials

Trial	Phase	Condition	Status	Sponsor
NCT02966652	Phase 1	Male Hypogonadism	Completed	NBIX

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Male Hypogonadism

Other drugs acting on AR

Testosterone FDA approved Bavdegalutamide Phase 1/2

More from Neurocrine UK

Crinecerfont FDA approved Valbenazine FDA approved Chronocort Phase 3 Luvadaxistat Phase 2 NBI-1065845 Phase 3 NBI-1065890 Phase 2 NBI-1070770 Phase 2 NBI-1117567 Phase 2 NBI-1117568 Phase 3 NBI-1117570 Phase 2 NBI-827104 Phase 2 NBI-921352 Phase 2

Sources

ClinicalTrials.gov NCT02966652

Updated Oct 3, 2026. Something wrong or missing? Report it on the NBIX page.

Follow NBIX, the company behind DITEST

See NBIX's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

NBIX catalysts and pipeline →

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z